Breast Carcinomas with Equivocal HER2/Neu Amplification: Morphologic Features, CEP17 Polysomy and HER2 Genetic Heterogeneity

被引：0
|
作者：
Astvatsaturyan, K. [1 ]
Bose, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
91
引用
收藏
页码：24A / 25A
页数：2
相关论文
共 50 条
  • [31] Clinicopathologic Features of Breast Cancers with HER2/CEP17 Ratio <2, HER2 Copy Number ≥4 and <6 Signals/Cell
    Xu, Jin
    Brogi, Edi
    Ventura, Katia
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah
    MODERN PATHOLOGY, 2019, 32
  • [32] Incidence and Significance of Fluorescent In Situ Hybridization (FISH) HER2 Gene Amplification by HER2 Gene Copy Number of ≥6.0 with Her2/CEP17 Ratio of <2.0 in Breast Cancer
    Apple, Sophia
    MODERN PATHOLOGY, 2017, 30 : 29A - 30A
  • [33] Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification
    Brunelli, Matteo
    Manfrin, Erminia
    Martignoni, Guido
    Miller, Keith
    Remo, Andrea
    Reghellin, Daniela
    Bersani, Samantha
    Gobbo, Stefano
    Eccher, Albino
    Chilosi, Marco
    Bonetti, Franco
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (05) : 678 - 682
  • [34] Clinicopathologic Features of Breast Cancers with HER2/CEP17 Ratio <2, HER2 Copy Number ≥4 and <6 Signals/Cell
    Xu, Jin
    Brogi, Edi
    Ventura, Katia
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah
    LABORATORY INVESTIGATION, 2019, 99
  • [35] Incidence and Significance of Fluorescent In Situ Hybridization (FISH) HER2 Gene Amplification by HER2 Gene Copy Number of ≥ 6.0 with Her2/CEP17 Ratio of <2.0 in Breast Cancer
    Apple, Sophia
    LABORATORY INVESTIGATION, 2017, 97 : 29A - 30A
  • [36] Assessments of HER2 Gene Status in Breast Carcinomas with Polysomy of Chromosome 17
    Gatalica, Z.
    Repertinger, S.
    Hatcher, L.
    Ulmer, P.
    LABORATORY INVESTIGATION, 2009, 89 : 41A - 41A
  • [37] HER2 Amplification Status in Breast Cancer: The Effect of Adjusting for "Polysomy 17"
    Gagne, I.
    Craddock, K. J.
    Mulligan, A. M.
    LABORATORY INVESTIGATION, 2013, 93 : 40A - 41A
  • [38] HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
    Hanna, Wedad M.
    Rueschoff, Josef
    Bilous, Michael
    Coudry, Renata A.
    Dowsett, Mitch
    Osamura, Robert Y.
    Penault-Llorca, Frederique
    van de Vijver, Marc
    Viale, Giuseppe
    MODERN PATHOLOGY, 2014, 27 (01) : 4 - 18
  • [39] Her2/Neu (HER2) Intratumoral Genetic Heterogeneity in Breast Cancer and Its Concurrent Axillary Metastases
    Astvatsaturyan, K.
    Bose, S.
    MODERN PATHOLOGY, 2013, 26 : 28A - 28A
  • [40] HER2 Amplification Status in Breast Cancer: The Effect of Adjusting for "Polysomy 17"
    Gagne, I.
    Craddock, K. J.
    Mulligan, A. M.
    MODERN PATHOLOGY, 2013, 26 : 40A - 41A
12345